What the biology looks like when you stop treating the pathways as separate subjects and look at them through the SBS lenses.

Imagine the body not as a collection of independent chemical factories, but as a living network that constantly has to maintain three things at once: intact boundaries (so the inside stays distinct from the outside), a clear sense of what belongs where (identity), and the ability to clear out what is no longer useful or has become toxic. At the same time it has to keep information and material flowing (throughput), correct problems without bankrupting itself (correction cost), and avoid getting stuck repeating the same broken pattern (replication). When those capacities stay flexible, the system can adapt. When they narrow and lock, the same restricted configuration starts showing up in many different tissues and disease labels.

That is the picture that emerges when you put serotonin, kynurenine, thyroid hormone, glutathione, nitric oxide, methylation, mitochondria, bile acids, and polyamines on the same table.

BIC — Boundary, Identity, Clearance

Several of the pathways sit right on the boundary between the host and the microbial world, and they help decide what is allowed to pass, what is recognised as self, and what gets cleared.

The gut lining and its mucus layer are a living boundary. Secondary bile acids and short-chain fatty acids produced by certain microbes help keep that boundary tight and the mucus healthy. Serotonin made in the gut wall also participates in motility and local signalling that supports barrier function. When those microbial functions thin out, the boundary becomes leakier. At the same time, the kynurenine pathway (especially when inflammation turns on IDO) and nitric oxide production shape immune “identity” — deciding which signals are tolerated and which trigger defence. Glutathione and the broader redox system are major clearance tools: they neutralise reactive molecules so they do not damage membranes or DNA. Thyroid hormone and mitochondrial activity influence how quickly cells turn over and how effectively damaged material is removed.

When any of these falter, you often see the same three failures appear together: the boundary becomes more permeable, the immune system starts reacting to things it used to ignore (loss of clear identity), and clearance slows so intermediate metabolites and oxidative by-products accumulate. One failure rarely stays isolated; it tends to compromise more than one BIC dimension at once.

TCVG — Trio, Choline, Vagus, Glymphatic

The “Trio” idea (mucus-associated microbial ecology as a measurable indicator of broader biome–host communication) shows up clearly. Certain microbes (spore-formers, Akkermansia-like organisms, bile-acid transformers) do not just sit there; they actively tune host serotonin production, bile-acid signalling, and short-chain fatty acid output. Those outputs talk to the host through the vagus nerve and through circulating metabolites that reach the brain. Sleep and glymphatic clearance (the brain’s overnight waste-removal system) are influenced by the same network: melatonin is downstream of serotonin, and mitochondrial and redox health affect how well the brain can clear during deep sleep. Choline sits in the middle of this — it is needed for membrane phosphatidylcholine (boundary integrity), for acetylcholine (vagal and cognitive signalling), and it feeds into methylation. When choline economy is strained, membranes, neurotransmission, and methylation all feel it.

So the pathways are not separate from TCVG; several of them are the biochemical language through which the microbial community, the vagus, and clearance systems speak to one another.

CTR — Correction Cost, Throughput, Replication

This is where the picture becomes especially sharp. Healthy systems keep multiple routes open and can switch between them with relatively low cost. Diseased configurations often show the opposite: fewer usable routes, higher cost to keep the remaining ones running, and a tendency to keep reproducing the same restricted state.

Look at tryptophan. Under calm conditions it can go to serotonin or to kynurenine or be used by microbes. Under chronic inflammation the IDO gate opens wide, most tryptophan is forced down the kynurenine road, serotonin production drops, and the system now depends on a narrower set of options. Restoring the original flexibility requires more resources (and often fails while the inflammatory signal continues). The same pattern appears with BH4: when oxidative stress oxidises it faster than it can be recycled, the enzymes that make serotonin, catecholamines, and nitric oxide all lose capacity at the same time, and the nitric oxide synthases start making superoxide instead. The system is now locked into a high-cost, low-output mode. Methylation shows it too: when demand for methyl groups is high or cofactors are short, the SAM:SAH ratio falls, methylation reactions slow, and the system has fewer ways to mark genes, make membranes, or process neurotransmitters. Correction becomes expensive.

Mitochondria and glutathione amplify the cost. Damaged mitochondria produce more reactive oxygen species, which further oxidise BH4 and consume glutathione, which further impairs energy production. The system is spending more and more just to stay in the same restricted state. That is high correction cost and low throughput, and the configuration tends to replicate itself across days and tissues.

Amino Acid and Peptide Grammar

Healthy systems appear to keep amino-acid pools and pathway choices relatively diverse and reversible. Restricted systems start reusing the same limited motifs. Tryptophan is forced into one dominant channel. Arginine is competed for by nitric oxide, polyamines, and the urea cycle, and under stress one or two of those win consistently. Cysteine is pulled hard toward glutathione at the expense of other uses. The enzymes themselves begin to favour certain substrates or become constitutively induced (IDO is a clear example). The “grammar” of the chemistry becomes less flexible — fewer possible sentences, more repetition of the same restricted phrases. This shows up in metabolomic signatures across neurological, inflammatory, and metabolic conditions even when the end-organ labels look different.

Regulatory Lock

This is the unifying observation. Many of the pathways can enter a self-reinforcing restricted state:

• Inflammation induces IDO → tryptophan is diverted → serotonin falls and kynurenine metabolites rise → immune and neural tone stay altered → inflammation is harder to resolve.
• Oxidative stress oxidises BH4 → nitric oxide production falls and superoxide rises → more oxidative stress → BH4 stays low.
• Microbial loss of key functions (bile-acid transformers, short-chain fatty acid producers, certain polyamine producers) reduces the signals that normally keep host serotonin, barrier, and metabolic enzymes in a flexible range → the host enzymes stay in the narrowed expression pattern.
• Methylation and redox constraints feed each other: low glutathione or high demand for cysteine pulls resources away from methylation, and poor methylation impairs the cell’s ability to regulate the very enzymes that control redox.

Once these loops close, simply adding more of a single substrate often does little, because the system is no longer configured to use it the original way. Recovery requires opening multiple gates at once — reducing the inflammatory drive, restoring redox capacity so BH4 can be recycled, re-introducing the microbial functions that send the right signals, and supporting the cofactors that keep the remaining enzymes flexible. That is why single-molecule or single-pathway approaches so often plateau.

The larger picture

What the combined evidence shows is not that every disease begins in the gut or that one cofactor explains everything. It shows that a relatively small set of shared resources and decision points (tryptophan partitioning, BH4 redox state, cysteine/glutathione capacity, SAM availability, key microbial functional guilds, iron and selenium status, mitochondrial integrity) sit at the crossroads of many pathways. When those nodes stay flexible, the system can route material and information in many directions and recover from insults. When they narrow and the feedback loops close, the same restricted operating state appears under different disease names.

That is the “monumental” pattern the mining surfaced: not a single new pathway, but the repeated observation that loss of metabolic flexibility and the emergence of self-reinforcing restricted configurations cut across the classical silos. The biology itself is already integrated. The silos were the artificial part.

That is the “monumental” pattern the mining surfaced: not a single new pathway, but the repeated observation that loss of metabolic flexibility and the emergence of self-reinforcing restricted configurations cut across the classical silos. The biology itself is already integrated. The silos were the artificial part.